Overview Request Sample Pages Request Customization Download PDF
You are viewing: Rest Of Latin America Preimplantation Genetic Testing Market analysis

The Rest Of Latin America Preimplantation Genetic Testing Market was valued at $7.1 Million in 2025 and projected to reach to $10.6 Million by 2030, representing a compound annual growth rate of 8.3%. Rest Of Latin America's preimplantation genetic testing market is positioned for steady expansion through 2030, supported by increasing healthcare infrastructure investments and growing middle-class populations seeking advanced reproductive solutions.

Rest Of Latin America Preimplantation Genetic Testing Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Latin America Preimplantation Genetic Testing Market Trends and Insights

  • This 8.3% compound annual growth rate reflects increasing adoption of advanced reproductive technologies across the region.
  • Rest Of Latin America is witnessing rising demand for genetic screening services driven by growing awareness of hereditary conditions and improved access to fertility clinics offering PGT solutions. The market in Rest Of Latin America is characterized by expanding healthcare infrastructure and rising disposable incomes among middle-class populations seeking assisted reproductive technologies.
  • Rest Of Latin America's fertility centers are increasingly integrating PGT into their service offerings to meet patient demand for genetic health screening.
  • Between 2025 and 2030, Rest Of Latin America is expected to see enhanced regulatory frameworks and greater investment in reproductive medicine, supporting market expansion and improved patient outcomes..

Key Market Statistics

  • CAGR (2025-2030) 8.3% CAGR
  • Market Size, 2025 ~USD 7.1 Million
  • Forecast, 2030 ~USD 10.6 Million
  • Country Rest Of Latin America

Rest Of Latin America Preimplantation Genetic Testing Market Overview

Market Valuation Growth :

Rest Of Latin America's PGT market is valued at $7.1 million in 2025, with projections reaching $10.6 million by 2030, representing a robust 8.3% CAGR driven by increasing fertility clinic adoption.

Regional Technology Adoption :

Advanced reproductive technologies are gaining traction across Rest Of Latin America as healthcare providers invest in genetic screening capabilities to meet rising patient demand for safer embryo selection.

Growing Awareness & Accessibility :

Increasing public awareness about genetic disorders and improved accessibility to PGT services in secondary cities is expanding the addressable market beyond major metropolitan centers in the region.

Competitive Market Dynamics :

Regional fertility clinics and diagnostic laboratories are expanding PGT offerings, creating competitive pricing pressures while driving service quality improvements across Rest Of Latin America.

Rest Of Latin America Preimplantation Genetic Testing Market Dynamics

  • The 8.3% CAGR reflects gradual but consistent adoption of PGT technologies as fertility clinics modernize their capabilities and patient education improves. Key growth drivers include rising awareness of genetic screening benefits, improving reimbursement policies in select countries, and partnerships between regional providers and international diagnostic companies.
  • However, regulatory variations across Rest Of Latin America and cost barriers in lower-income segments may moderate growth rates compared to more developed markets, requiring localized market strategies..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Rest Of Latin America's PGT market is valued at $7.1 million in 2025 and will reach $10.6 million by 2030, growing at 8.3% CAGR.
      • Rest Of Latin America is experiencing increased adoption of genetic screening services due to rising awareness of hereditary conditions and improved fertility clinic accessibility.
      • Rest Of Latin America's market growth is driven by expanding healthcare infrastructure and rising disposable incomes supporting demand for assisted reproductive technologies.
      • Rest Of Latin America is expected to benefit from enhanced regulatory frameworks and increased investment in reproductive medicine through 2030.

      Preimplantation Genetic Testing Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment SINGLE GENE DISORDERS (Application)
      Forecast Period 2025–2030
      Growth Rate CAGR of 10.5% from 2025 to 2030
      Largest Segment PREIMPLANTATION GENETIC SCREENING (Procedure Type)
      Market Size Base Year (Billions) ~USD 0.69 (2025)
      Revenue Forecast (Billions) ~USD 1.14 (2030)
      Segments Covered Product & Service, Procedure Type, Technology, Application, Type, Type Of Cycle, End User

      Rest Of Latin America Preimplantation Genetic Testing Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product & Service

      • Instruments
      • Reagents & Consumables
      • Software & Services

      By Procedure Type

      • Preimplantation Genetic Diagnosis
      • Preimplantation Genetic Screening

      By Technology

      • Comparative Genomic Hybridization
      • Fluorescence In Situ Hybridization
      • Next-Generation Sequencing
      • Polymerase Chain Reaction
      • Single-Nucleotide Polymorphism

      By Application

      • Aneuploidy
      • Gender Identification
      • Hla Typing
      • Single Gene Disorders
      • Structural Chromosomal Abnormalities
      • X-Linked Disorders

      By Type

      • Deletions
      • Duplications
      • Inversions
      • Translocations

      By Type Of Cycle

      • Fresh Donor
      • Fresh Non-Donor
      • Frozen Donor
      • Frozen Non-Donor

      By End User

      • Diagnostic Laboratories
      • Fertility Clinics
      • Hospitals
      • Other End Users

      Target Audience

      • Fertility Clinic Operators : Need market data to justify PGT service investments, benchmark against regional competitors, and understand patient demand trends across Rest Of Latin America's secondary and tertiary markets.
      • Diagnostic Laboratory Providers : Require insights into regional testing volumes, pricing benchmarks, and growth opportunities to expand PGT service portfolios and establish partnerships with fertility centers in Rest Of Latin America.
      • Medical Device & Reagent Manufacturers : Seek market intelligence on adoption rates, competitive products, and distribution channels to develop localized sales strategies and identify key opinion leaders in Rest Of Latin America.
      • Healthcare Investment Firms : Need comprehensive market analysis to evaluate investment opportunities in reproductive health companies, fertility clinics, and diagnostic labs operating across Rest Of Latin America.
      • Healthcare Policy & Regulatory Bodies : Require market data to inform reimbursement policies, regulatory frameworks, and healthcare infrastructure planning for genetic testing services in Rest Of Latin America.

      Key Companies in the Rest Of Latin America Preimplantation Genetic Testing Market

      CompanyHQOwnershipStrongest segments
      CIMARON LABELPressure-sensitive paper labels,Film and durable labels,Specialty/custom applications,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLaboratory Products and Biopharma Services,Life Sciences Solutions,Analytical Instruments,
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      REVVITYUnited StatesPublic CompanyReagents, Assays, and Consumables,Instruments and Detection/Imaging Platforms,Software, Subscriptions, and Informatics,
      COOPERCOMPANIESUnited StatesPublic CompanySpherical contact lenses,Toric and multifocal contact lenses,Fertility consumables, equipment, and services,
      ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
      TAKARA BIO INC.JapanPrivate CompanyResearch reagents for genetic and cellular research,Instruments (PCR instruments and cellular analysis devices),In vitro diagnostics (including COVID-19 testing),
      VITROLIFESwedenPublic CompanyIVF media and oil,Labware (dishes, pipettes, tubes, VitroTemp, eWitness-related consumables),Cryopreservation solutions,

      CIMARON LABEL

      Insufficient information provided to generate description.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in serving science, providing laboratory equipment, reagents, and analytical instruments.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. The company provides life sciences, diagnostics, and applied chemical markets with instruments and software.

      REVVITY

      Revvity is a United States-based public company founded in 1937 with 11,000 employees. The company provides analytical technologies and solutions for research, diagnostics, and applied markets.

      COOPERCOMPANIES

      CooperCompanies is a United States-based public company founded in 1958 with 15,000 employees. The company operates in the medical device sector, primarily focused on contact lenses and eye care products.

      ABBOTT

      Abbott is a United States-based public company founded in 1888 with 115,000 employees. The company is a diversified healthcare manufacturer producing pharmaceuticals, diagnostics, nutritional products, and medical devices.

      TAKARA BIO INC.

      Takara Bio Inc. is a Japan-based private company founded in 2002 with 1,779 employees. The company specializes in biotechnology research and development.

      VITROLIFE

      Vitrolife is a Sweden-based public company founded in 1989 with 1,103 employees. The company develops and manufactures products for assisted reproduction and embryo culture.

      Reasons to Buy this Report

      • Regional Market Sizing & Forecasts : Obtain precise market valuations specific to Rest Of Latin America with detailed 2025-2030 projections, enabling accurate budget allocation and revenue forecasting for regional expansion strategies.
      • Competitive Landscape Intelligence : Understand key players, market consolidation trends, and competitive positioning within Rest Of Latin America's PGT sector to identify partnership and acquisition opportunities.
      • Growth Driver Analysis : Identify specific factors driving the 8.3% CAGR in Rest Of Latin America, including regulatory changes, reimbursement trends, and technology adoption patterns unique to the region.
      • Customer Segmentation Insights : Access detailed breakdowns of fertility clinics, diagnostic laboratories, and patient demographics across Rest Of Latin America to refine go-to-market strategies and service offerings.
      • Risk & Opportunity Assessment : Evaluate market barriers, regulatory challenges, and emerging opportunities specific to Rest Of Latin America to develop informed investment and expansion decisions.

      Frequently asked questions

      What is the current market size of preimplantation genetic testing in Rest Of Latin America?

      Rest Of Latin America's preimplantation genetic testing market is valued at $7.1 million in 2025.

      What is the projected market size for Rest Of Latin America's PGT market by 2030?

      Rest Of Latin America's PGT market is forecast to reach $10.6 million by 2030.

      What is the growth rate of the PGT market in Rest Of Latin America?

      Rest Of Latin America's preimplantation genetic testing market is growing at a compound annual growth rate of 8.3% from 2025 to 2030.

      What factors are driving PGT market growth in Rest Of Latin America?

      Rest Of Latin America's PGT market growth is driven by increased awareness of hereditary conditions, expanding healthcare infrastructure, rising disposable incomes, and greater accessibility to fertility clinics offering genetic screening services.

      How is Rest Of Latin America's PGT market expected to evolve through 2030?

      Rest Of Latin America's PGT market is expected to benefit from enhanced regulatory frameworks, increased investment in reproductive medicine, and broader integration of genetic testing into fertility center service offerings.

      RESEARCH METHODOLOGY

      This research extensively used secondary sources, directories, and databases to gather valuable information for analyzing the global preimplantation genetic testing market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives, and industry consultants, to obtain and verify important qualitative and quantitative data and evaluate the market’s growth prospects. The global market size estimated through secondary research was cross-checked with inputs from primary research to determine the final market size.

      Secondary Research

      Secondary research was mainly used to gather information for the detailed technical, market, and commercial analysis of the preimplantation genetic testing market. The secondary sources for this study include the World Health Organization (WHO), World Bank, Human Fertilization and Embryology Authority (HFEA), International Federation of Fertility Societies (IFFS), American Society for Reproductive Medicine (ASRM), Australia and New Zealand Assisted Reproduction Database (ANZARD), Centers for Disease Control and Prevention (CDC), Society for Assisted Reproductive Technology (SART), National Health Service (NHS), Indian Fertility Society (IFS), British Fertility Society (BFS), European Society of Human Reproduction and Embryology (ESHRE), Association for Fertility and Reproductive Health (AFRH), German Society of Reproductive Medicine (DGRM), Canadian Fertility & Andrology Society (CFAS), Indian Society for the Study of Reproduction and Fertility (ISSRF), Spanish Fertility Society (Sociedad Española de Fertilidad-SEF), Japan Society for Reproductive Medicine, National Registry of Assisted Reproductive Technology and Surrogacy Registry, Journal of Human Reproductive Sciences, American Congress of Obstetricians and Gynecologists (ACOG), European Society of Human Genetics (ESHG); ACS Journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations.

      Secondary data was collected and analyzed to determine the overall size of the global preimplantation genetic testing market, which was then validated through primary research. These sources also provided key information about major players, market classification, and segmentation based on industry trends, regional and country-level markets, market developments, and technological perspectives.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

      Preimplantation Genetic Testing Market

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The top-down and bottom-up approaches were used to estimate & validate the total size of the preimplantation genetic testing market. These methods were also used extensively to estimate the size of various market segments.

      Preimplantation Genetic Testing Market

      Data Triangulation

      After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.

      Market Definition

      Preimplantation genetic testing (PGT) examines embryos during in vitro fertilization (IVF) before possible transfer to a woman's uterus. This is done to test a range of genetic problems that can cause implantation failure, miscarriage, and birth defects in a resulting child.

      Preimplantation genetic testing refers to the three types of tests that may be performed on embryos during IVF:

      • Preimplantation genetic screening for abnormal chromosome number (PGT-A)
      • Preimplantation genetic testing for monogenic (individual) disease (PGT-M)
      • Preimplantation genetic testing structural rearrangement (PGT-SR) for known chromosomal misarrangements such as inversion and translocation.

      The study offers an in-depth analysis of the preimplantation genetic testing market, examining contemporary market trends and developments, as well as its potential growth from 2025 to 2030. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key preimplantation genetic testing product and service providers.

      Stakeholders

      • Contract research organizations (CROs)
      • Contract development and manufacturing organizations (CDMOs)
      • In vitro fertilization (IVF) centers and fertility clinics
      • Life science companies
      • Fertility clinics
      • Academic & research institutes
      • Private research institutes
      • Venture capitalists & investors
      • Market research & consulting firms
      • Government associations
      • Medical institutions & universities
      • Hospitals & clinics

      Report Objectives

      • To define, describe, and forecast the preimplantation genetic testing market based on procedure type, technology, product & service, application, type of cycle, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall preimplantation genetic testing market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players in the preimplantation genetic testing market and comprehensively analyze their core competencies and market rankings
      • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the preimplantation genetic testing market
      • To benchmark players within the preimplantation genetic testing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product strategy

      Get the Full Preimplantation Genetic Testing Market Report

      Full forecast, segment splits, and company analysis for all Preimplantation Genetic Testing Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status